Skip to main content
SpringerLink
Log in

HIF-1α P582S and A588T polymorphisms and digestive system cancer risk—a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Hypoxia-inducible factor-1 (HIF-1) influences cancer progression and metastasis through various mechanisms, and HIF-1α polymorphisms are reportedly associated with many cancers; however, the associations of HIF-1α P582S and A588T polymorphisms with the risk of digestive system cancer remain inconclusive. To understand the role of HIF-1α P582S and A588T genotypes in digestive cancer development, we conducted a comprehensive meta-analysis involving 1,517 cases and 3,740 controls. Overall, the P582S polymorphism was not significantly associated with digestive system cancers in all genotypes. By contrast, the A588T polymorphism was significantly associated with digestive system cancers in the dominant model (TT/AT vs. AA: OR = 3.17, 95 % CI: 1.21, 8.25; P heterogeneity < 0.001). In subgroup analysis for cancer types, the two polymorphisms were only associated with increased risk of pancreatic cancer (P582S: SS vs. PP: OR = 2.51, 95 % CI: 1.31, 4.81; SS vs. PP/PS: OR = 8.73, 95 % CI: 1.33, 57.1; A588T: TT vs. AA: OR = 9.30, 95 % CI: 1.12, 77.6; P heterogeneity = 0.478; TT vs. AA/AT: OR = 3.14, 95 % CI: 1.99, 4.97; P heterogeneity = 0.098; TT/AT vs. AA: OR = 8.65, 95 % CI: 1.05, 71.6; P heterogeneity = 0.418). According to the source of ethnicity, the P582S and the A588T polymorphisms are both significantly associated with an increased risk of cancer among Caucasians in the homozygote model (SS vs. PP: OR = 2.41, 95 % CI: 1.24, 4.691; P heterogeneity = 0.010; TT vs. AA: OR = 98.6, 95 % CI: 4.37, 2,224; P heterogeneity = 0.040) and the recessive model (SS vs. PP/PS: OR = 9.48, 95 % CI: 1.12, 80.3; P heterogeneity < 0.001; TT vs. AA/AT: OR = 82.7, 95 % CI: 3.79, 1,802; P heterogeneity = 0.041). Our findings suggest that the HIF-1α A588T polymorphism is significantly associated with higher cancer risk and the P582S polymorphism is significantly associated with pancreatic cancer risk. Furthermore, the effect of both polymorphisms on digestive system cancer is more pronounced among Caucasians than that among Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Yoshimura M, Itasaka S, Harada H, Hiraoka M. Microenvironment and radiation therapy. Biomed Res Int. 2013;2013:685308.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  2. Tsai YP, Wu KJ. Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci. 2012;19:102.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Zhao T, Lv J, Zhao J, Nzekebaloudou M. Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis. J Exp Clin Cancer Res. 2009;28:159.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999;59:5830–5.

    PubMed  CAS  Google Scholar 

  5. Tanimoto K, Yoshiga K, Eguchi H, et al. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis. 2003;24:1779–83.

    Article  PubMed  CAS  Google Scholar 

  6. Horree N, Groot AJ, van Hattem WA, et al. HIF-1A gene mutations associated with higher microvessel density in endometrial carcinomas. Histopathology. 2008;52:637–9.

    Article  PubMed  CAS  Google Scholar 

  7. Liu J, Zhang HX. 1790 G/A polymorphism, but not 1772 C/T polymorphism, is significantly associated with cancers: an update study. Gene. 2013;523:58–63.

    Article  PubMed  CAS  Google Scholar 

  8. Frank B, Hoffmeister M, Klopp N, et al. Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis. 2010;31:1381–6.

    Article  PubMed  CAS  Google Scholar 

  9. Kang MJ, Jung SA, Jung JM, et al. Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer. Anticancer Res. 2011;31:575–84.

    PubMed  CAS  Google Scholar 

  10. Knechtel G, Szkandera J, Stotz M, et al. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog. 2010;49:805–9.

    PubMed  CAS  Google Scholar 

  11. Kuwai T, Kitadai Y, Tanaka S, et al. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep. 2004;12:1033–7.

    PubMed  CAS  Google Scholar 

  12. Chen MK, Chiou HL, Su SC, et al. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol. 2009;45:e222–6.

    Article  PubMed  CAS  Google Scholar 

  13. Alves LR, Fraga CA, Oliveira MV, et al. High HIF-1alpha expression genotypes increase odds ratio of oral cancer. Head Neck Oncol. 2012;4:87.

    PubMed  CAS  Google Scholar 

  14. Munoz-Guerra MF, Fernandez-Contreras ME, Moreno AL, et al. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol. 2009;16:2351–8.

    Article  PubMed  Google Scholar 

  15. Ruiz-Tovar J, Fernandez-Contreras ME, Martin-Perez E, Gamallo C. Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer. Tumori. 2012;98:364–9.

    PubMed  CAS  Google Scholar 

  16. Wang X, Liu Y, Ren H, et al. Polymorphisms in the hypoxia-inducible factor-1alpha gene confer susceptibility to pancreatic cancer. Cancer Biol Ther. 2011;12:383–7.

    Article  PubMed  CAS  Google Scholar 

  17. Ling TS, Shi RH, Zhang GX, et al. Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis. 2005;6:155–8.

    Article  PubMed  CAS  Google Scholar 

  18. Hsiao PC, Chen MK, Su SC, et al. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol. 2010;102:163–9.

    Article  PubMed  CAS  Google Scholar 

  19. Li K, Zhang Y, Dan Z, et al. Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans. Biochem Genet. 2009;47:625–34.

    Article  PubMed  CAS  Google Scholar 

  20. Fransen K, Fenech M, Fredrikson M, et al. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog. 2006;45:833–40.

    Article  PubMed  CAS  Google Scholar 

  21. Szkandera J, Knechtel G, Stotz M, et al. Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis. Anticancer Res. 2010;30:2393–7.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Natural Science Foundation of China (No. 81272504), the Innovation Team [No. LJ201123 (EH11)], Jiangsu Provincial Science and Technology Projects [BK2011854 (DA11)], “333” Project of Jiangsu Province [BRA2012210 (RS12)], and research grants from Chinese Society of Clinical Oncology [T-H2010-033 (KA10)].

Conflicts of interest

The author(s) declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300, Nanjing, 210029, China

    Xi Yang, Chi Zhang, Hong-Cheng Zhu, Qin Qin, Jia Liu, Li-Ping Xu & Xin-Chen Sun

  2. The Comprehensive Cancer Center, Nanjing Drum Tower Hospital and Clinical College of Nanjing Medical University, Nanjing, China

    Lian-Jun Zhao

  3. Department of Radiotherapy, Second People’s Hospital of Lian Yungang, Lian Yungang, China

    Qu Zhang & Jian-Xin Ma

  4. Department of Radiation Oncology, Nantong Tumor Hospital, Nantong, China

    Jing Cai

  5. Department of Synthetic Internal Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

    Hong-Yan Cheng

Authors
  1. Xi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong-Cheng Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qin Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lian-Jun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jia Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li-Ping Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jing Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jian-Xin Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hong-Yan Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xin-Chen Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xin-Chen Sun.

Additional information

Xi Yang and Chi Zhang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, X., Zhang, C., Zhu, HC. et al. HIF-1α P582S and A588T polymorphisms and digestive system cancer risk—a meta-analysis. Tumor Biol. 35, 2825–2830 (2014). https://doi.org/10.1007/s13277-013-1375-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1375-x

Keywords

Search

Navigation